Nuclear and nucleolar ultrastructural lesions induced by 1-nitro-9-aminoacridine (C-283) in human ovarian carcinoma cells.
D000166:Acridines / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001202:Ascitic Fluid / Q000187:drug effects; D002466:Cell Nucleolus / Q000187:drug effects / Q000648:ultrastructure*; D002467:Cell Nucleus / Q000187:drug effects / Q000648:ultrastructure*; D002843:Chromatin; D004123:Dimethylamines / Q000494:pharmacology; D005122:Exudates and Transudates / Q000187:drug effects; D005260:Female; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000648:ultrastructure; D008854:Microscopy, Electron; D009574:Nitro Compounds / Q000494:pharmacology; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology*; D010996:Pleural Effusion / Q000187:drug effects; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012270:Ribosomes / Q000187:drug effects / Q000648:ultrastructure
D000166:Acridines; D000970:Antineoplastic Agents; D002843:Chromatin; D004123:Dimethylamines; D009574:Nitro Compounds; D012334:RNA, Neoplasm